Explore the vast range of titles available.

Besides a global health crisis, the COVID-19 pandemic has potential to have a severe and long-lasting psychological impact on frontline healthcare workers such as paramedics. It is imperative to shed light on these mental health issues and employ interventions to protect the mental wellness of this vulnerable group of healthcare workers.

Survey sampling is a widely used technique for collecting data from a subset of a bigger population. Among its methods, stratified random sampling is particularly valuable for yielding precise inferences about distinct subgroups within a population by dividing the population into mutually exclusive strata and sampling from each group. This approach reduces sampling error and enhances the accuracy of population estimates. In this study, we propose a set of improved calibrated log-ratio-type estimators for estimating population variance under a stratified sampling framework. The performance of three proposed estimators is evaluated and compared in terms of the mean squared error. A simulation study is conducted to assess the efficiency of the estimators, complemented by a real-life application to validate the simulation results. The findings demonstrate that the proposed calibrated log-ratio variance estimators outperform existing methods by achieving lower mean squared error.

Ingrown toenails, a common and often painful condition, frequently require surgical intervention for effective management. This study aimed to compare the clinical outcomes of partial nail avulsion (PNA) with and without adjunctive phenolization, specifically focusing on recurrence and postoperative wound infection rates. This prospective comparative interventional study was conducted in the Department of General Surgery at Jinnah Hospital, Lahore, over a six-month period from July 15, 2023, to January 14, 2024. A total of 140 patients were included and randomly divided into two groups: 70 patients in Group A (PNA with phenolization) and 70 patients in Group B (PNA without phenolization). For categorical variables, statistical analysis was conducted using the chi-square test; a p-value of 0.05 was regarded statistically significant. To assess other influencing elements, a subgroup study by age and gender was carried out. Recurrence was significantly lower in Group A with one patient (1.43%) compared to seven patients (10.0%) in Group B (p=0.029). Wound infection was also reduced in Group A, occurring in four patients (5.71%) versus 12 patients (17.14%) in Group B (p=0.034). Among younger patients (12-35 years), recurrence was 0 out of 46 (0.0%) in Group A versus 6 out of 41 (14.63%) in Group B (p=0.007), while in older patients (36-60 years), recurrence rates were similar (4.17% vs. 3.45%; p=0.891). Female patients in Group A had no recurrence (0 out of 31; 0.0%) compared to 4 out of 32 (12.5%) in Group B (p=0.042). Our findings indicate that PNA combined with phenolization offers superior outcomes in reducing recurrence rates, especially among younger and female patients, compared to PNA alone. While overall infection rates were lower with phenolization, stratified analysis did not consistently show statistical significance, and no notable adverse effects on wound healing were observed, supporting phenol's clinical utility with minor limitations.

Background: COVID-19 was initially considered to be a respiratory illness, but current findings suggest that SARS-CoV-2 is increasingly expressed in cardiac myocytes as well. COVID-19 may lead to cardiovascular injuries, resulting in myocarditis, with inflammation of the heart muscle. Objective: This systematic review collates current evidence about demographics, symptomatology, diagnostic, and clinical outcomes of COVID-19 infected patients with myocarditis. Methods: In accordance with PRISMA 2020 guidelines, a systematic search was conducted using PubMed, Cochrane Central, Web of Science and Google Scholar until August, 2021. A combination of the following keywords was used: SARS-CoV-2, COVID-19, myocarditis. Cohorts and case reports that comprised of patients with confirmed myocarditis due to COVID-19 infection, aged >18 years were included. The findings were tabulated and subsequently synthesized. Results: In total, 54 case reports and 5 cohorts were identified comprising 215 patients. Hypertension (51.7%), diabetes mellitus type 2 (46.4%), cardiac comorbidities (14.6%) were the 3 most reported comorbidities. Majority of the patients presented with cough (61.9%), fever (60.4%), shortness of breath (53.2%), and chest pain (43.9%). Inflammatory markers were raised in 97.8% patients, whereas cardiac markers were elevated in 94.8% of the included patients. On noting radiographic findings, cardiomegaly (32.5%) was the most common finding. Electrocardiography testing obtained ST segment elevation among 44.8% patients and T wave inversion in 7.3% of the sample. Cardiovascular magnetic resonance imaging yielded 83.3% patients with myocardial edema, with late gadolinium enhancement in 63.9% patients. In hospital management consisted of azithromycin (25.5%), methylprednisolone/steroids (8.5%), and other standard care treatments for COVID-19. The most common in-hospital complication included acute respiratory distress syndrome (66.4%) and cardiogenic shock (14%). On last follow up, 64.7% of the patients survived, whereas 31.8% patients did not survive, and 3.5% were in the critical care unit. Conclusion: It is essential to demarcate COVID-19 infection and myocarditis presentations due to the heightened risk of death among patients contracting both myocardial inflammation and ARDS. With a multitude of diagnostic and treatment options available for COVID-19 and myocarditis, patients that are under high risk of suspicion for COVID-19 induced myocarditis must be appropriately diagnosed and treated to curb co-infections.

This review examines the current applications, benefits, challenges, and future potential of artificial intelligence (AI) and immersive aviation technologies. AI has been applied across various domains, including flight operations, air traffic control, maintenance, and ground handling. AI enhances aviation safety by enabling pilot assistance systems, mitigating human error, streamlining safety management systems, and aiding in accident analysis. Lightweight AI models are crucial for mobile applications in aviation, particularly for resource-constrained environments such as drones. Hardware considerations involve trade-offs between energy-efficient field-programmable gate arrays and power-consuming graphics processing units. Battery and thermal management are critical for mobile device applications. Although AI integration has numerous benefits, including enhanced safety, improved efficiency, and reduced environmental impact, it also presents challenges. Addressing algorithmic bias, ensuring cybersecurity, and managing the relationship between human operators and AI systems are crucial. The future of aviation will likely involve even more sophisticated AI algorithms, advanced hardware, and increased integration of AI with augmented reality and virtual reality, creating new possibilities for training and operations, and ultimately leading to a safer, more efficient, and more sustainable aviation industry.

Introduction The Accreditation Council of Graduate Medical Education requires all Graduate Medical Education programs to show evidence of scholarly activity. Fulfilling this obligation remains a challenge for residency programs and remains a common citation by the specialty Residency Review Committees, especially in community hospital settings with limited academic resources. This study evaluated the impact of implementing a bundled intervention on resident scholarly activity within a family medicine residency program in a community hospital. Methods This study employed a quasiexperimental pre- and postdesign to assess the impact of a multifaceted bundled intervention. The scholarly output of residents graduating between 2016 and 2018 (preintervention) was compared to those graduating from 2019 to 2021 (postintervention). Statistical Process Control charts with JMP Pro 17.0 were used to display data and perform phase analysis. Fisher's exact test and the chi-square test were used to compare the demographics, while the Mann-Whitney U-test and one-way analysis of variance were also used to detect the difference in scholarly output between the 2 groups. Results Thirty-one family medicine residents graduated from the program in the study period. A significant increase in the average number of scholarly activities, including all manuscripts and presentations, was noted. The average number of all-scholarly activities increased 4-fold postintervention (P < .001). The increase in all-presentations and all-manuscripts was also statistically significant postintervention (P < .001 and .0038, respectively). Conclusions Implementing a multifaceted bundled intervention containing a 13-step structured roadmap with a quality improvement approach is associated with increasing residents’ scholarly output in residency programs at a community hospital.

Background The evolutionary stages of manufacturing have led us to conceptualize the use of Industry 4.0 for COVID-19 (coronavirus disease 2019), powered by Industry 4.0 technologies. Using applications of integrated process optimizations reliant on digitized data, we propose novel intelligent networks along the vaccine value chain. Vaccine 4.0 may enable maintenance processes, streamline logistics, and enable optimal production of COVID-19 vaccines. Vaccine 4.0 Framework The challenge in applying Vaccine 4.0 includes the requirement of large-scale technologies for digitally transforming manufacturing, producing, rolling-out, and distributing vaccines. With our framework, Vaccine 4.0 analytics will target process performance, process development, process stability, compliance, quality assessment, and optimized maintenance. The benefits of digitization during and post the COVID-19 pandemic include first, the continual assurance of process control, and second, the efficacy of big-data analytics in streamlining set parameter limits. Digitization including big data-analytics may potentially improve the quality of large-scale vaccine production, profitability, and manufacturing processes. The path to Vaccine 4.0 will enhance vaccine quality, improve efficacy, and compliance with data-regulated requirements. Discussion Fiscal and logistical barriers are prevalent across resource-limited countries worldwide. The Vaccine 4.0 framework accounts for expected barriers of manufacturing and equitably distributing COVID-19 vaccines. With amalgamating big data analytics and biometrics, we enable the identification of vulnerable populations who are at higher risk of disease transmission. Artificial intelligence powered sensors and robotics support thermostable vaccine distribution in limited capacity regions, globally. Biosensors isolate COVID-19 vaccinations with low or limited efficacy. Finally, Vaccine 4.0 blockchain systems address low- and middle-income countries with limited distribution capacities. Conclusion Vaccine 4.0 is a viable framework to optimize manufacturing of vaccines during and post the COVID-19 pandemic.

Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is known for the multiple mutations and forms that have rapidly spread across the world. With the imminent challenges faced by low- and middle-income countries in curbing the public health fallbacks due to limited resources, mucormycosis emerged as a fungal infection associated with high mortality. In this rapid review, we explored MEDLINE, Cochrane, Web of Science, WHO Global Database, and the search engine—Google Scholar for articles listed until July 2021 and presented a narrative synthesis of findings from 39 articles. The epidemiology, causative factors, incidence parameters, pharmacological treatment, and recommendations for low- and middle-income countries are enlisted. This study concludes that a majority of the globally reported COVID-19 associated mucormycosis cases stemmed from India. Individuals receiving systemic corticosteroids or who have a history of diabetes mellitus are more prone to contracting the disease. Public health authorities in LMIC are recommended to strengthen antifungal therapies for COVID-19 associated mucormycosis and to strategize reduction in diabetes mellitus prevalence.

ABSTRACT Asthma is a heterogenous disease with different endotypes. Among the various causative agents of asthma, allergens and genetic susceptibility play a key role. HLA is a complex region, and most of the GWAS studies on asthma are limited to simple gene markers. This study aimed to determine the association of HLA DRB1 alleles with atopic asthma in the Pakistani population. Blood samples of 568 subjects were collected from Punjab, Pakistan. HLA typing was performed by using sequence-specific primers (SSP). Total immunoglobulin E (IgE) was estimated by ELISA. Graph pad Prism 8 was used for statistical analysis. HLA DRB1* 0701-02 and HLA DRB1* 1301-04 showed a positive association with atopic asthma having an odd's ratio (OR) of 2.173 and 3.564 respectively. While HLA DRB1* 1101-04 and HLA DRB1* 1201-02 showed a negative association having OR of 0.4853 and 0.4299 respectively. HLA DRB1* 0701-02 had a positive association with family history (p = <0.0001*, OR= 3.641, 95% CI= 1.852-7.257) and female gender (p= 0.0003). Total IgE level was high in asthma patients (Mean = 508.7 IU/ml). In conclusion, this study suggested the association of atopic asthma with HLA DRB1 alleles in the Pakistani population of the Punjab region. Our study reveals that two HLA DRB1 alleles have a positive, and two alleles have a negative association with atopic asthma in the Pakistani population. This finding emphasized that further large-scale studies are needed in the Pakistani population to determine the association of atopic asthma with genetic susceptibility.

Synovial sarcoma is a rare mesenchymal tumor, and its occurrence as a primary renal tumor is exceedingly rare. We are presenting a case of renal synovial sarcoma with lung involvement in a 47-year-old female patient who initially presented with typical renal symptoms, including blood in urine and left flank pain. Imaging revealed a large renal mass with extension into the renal vein and metastatic nodules in the lungs. Histopathological examination and genetic analysis confirmed monophasic synovial sarcoma with SYT-SSX2 translocation. Treatment included radical nephrectomy followed by systemic chemotherapy with doxorubicin and ifosfamide. Despite the initial response, the disease progressed, leading to fatal complications. This case highlights the diagnostic challenges, limited treatment options, and poor prognosis associated with primary renal synovial sarcoma.